Lynne Laube - Jul 14, 2021 Form 4 Insider Report for Cardlytics, Inc. (CDLX)

Signature
/s/ Kirk Somers, Attorney-in-Fact
Stock symbol
CDLX
Transactions as of
Jul 14, 2021
Transactions value $
-$572,593
Form type
4
Date filed
7/16/2021, 04:50 PM
Previous filing
Jun 7, 2021
Next filing
Dec 20, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CDLX Common Stock Options Exercise $67.5K +3.38K +1.09% $20.00 312K Jul 14, 2021 Direct F1
transaction CDLX Common Stock Sale -$245K -1.98K -0.63% $123.77* 310K Jul 14, 2021 Direct F1, F2
transaction CDLX Common Stock Sale -$137K -1.1K -0.36% $124.56* 309K Jul 14, 2021 Direct F1, F3
transaction CDLX Common Stock Sale -$37.7K -300 -0.1% $125.77* 308K Jul 14, 2021 Direct F1, F4
transaction CDLX Common Stock Options Exercise $42.8K +2.14K +0.69% $20.00 310K Jul 15, 2021 Direct F1
transaction CDLX Common Stock Sale -$36.1K -300 -0.1% $120.42* 310K Jul 15, 2021 Direct F1, F5
transaction CDLX Common Stock Sale -$48.9K -400 -0.13% $122.29* 310K Jul 15, 2021 Direct F1, F6
transaction CDLX Common Stock Sale -$78.5K -638 -0.21% $123.03* 309K Jul 15, 2021 Direct F1, F7
transaction CDLX Common Stock Sale -$87.5K -700 -0.23% $124.95* 308K Jul 15, 2021 Direct F1, F8
transaction CDLX Common Stock Sale -$12.6K -100 -0.03% $125.56* 308K Jul 15, 2021 Direct F1
holding CDLX Common Stock 14.6K Jul 14, 2021 See Footnote F9
holding CDLX Common Stock 14.6K Jul 14, 2021 See Footnote F10

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CDLX Employee Stock Option (Right to Buy) Options Exercise $0 -3.38K -7.12% $0.00 44K Jul 14, 2021 Common Stock 3.38K $20.00 Direct F1, F11
transaction CDLX Employee Stock Option (Right to Buy) Options Exercise $0 -2.14K -4.86% $0.00 41.9K Jul 15, 2021 Common Stock 2.14K $20.00 Direct F1, F11
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2020.
F2 The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $123.14 to $124.12, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4), (5), (6), (7) and (8) to this Form 4.
F3 The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $124.15 to $124.895, inclusive.
F4 The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $125.70 to $125.90, inclusive.
F5 The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $120.07 to $120.66, inclusive.
F6 The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $121.725 to $122.64, inclusive.
F7 The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $122.80 to $123.23, inclusive.
F8 The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $124.47 to $125.30, inclusive.
F9 The reportable securities are held by the 2013 Lynne Marie Laube GRAT fbo Keegan George Allbright.
F10 The reportable securities are held by the 2013 Lynne Marie Laube GRAT fbo Hayley Marie Allbright.
F11 Fully vested.